APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Oral Analgesics

Compare research editions
View pricing & licenses

Selected research

Industry Research

OTC Oral Analgesics Industry Research Report 2026

22 December 2025141 pages

Choose your research edition.

Industry ResearchOTC Oral Analgesics Industry Research Report 2026141 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Oral Analgesics Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal OTC Oral Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Oral Analgesics Market Outlook and Growth Opportunities 2026214 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Oral Analgesics Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global OTC Oral Analgesics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the OTC Oral Analgesics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the OTC Oral Analgesics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the OTC Oral Analgesics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of OTC Oral Analgesics include Rundu Pharmaceutical, Yuanhe Pharmaceutical, Xinxiang Xinhui Yaoye, Southwest Pharmaceutical, Topfond Pharmaceutical, Sun Pharmaceutical, Sandoz, Sanofi and Johnson & Johnson, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global OTC Oral Analgesics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to OTC Oral Analgesics.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

OTC Oral Analgesics Market by Company

Rundu Pharmaceutical

Yuanhe Pharmaceutical

Xinxiang Xinhui Yaoye

Southwest Pharmaceutical

Topfond Pharmaceutical

Sun Pharmaceutical

Sandoz

Sanofi

Johnson & Johnson

Novartis

Jiangxi Pharmaceutical

Hongxing Pharmaceutical

Pfizer

Huazhong Pharmaceutical

Dingchang Pharmaceutical

Guangdong Heping Pharmacy

Bangmin Pharmaceutical

GSK

Bayer

AstraZeneca

Taisho Pharmaceutical

SSP Co. Ltd.

MSD

Merck Group

Mallinckrodt

Kowa Company

Janssen Pharmaceuticals

Hisamitsu Pharmaceutical

Endo Pharmaceuticals

OTC Oral Analgesics Segment by Type

Aspirin

Ibuprofen

Acetaminophen

Naproxen

Other

OTC Oral Analgesics Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

OTC Oral Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Oral Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Oral Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Oral Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of OTC Oral Analgesics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global OTC Oral Analgesics Market Size by Type (2021-2026) & (US$ Million) Table 6. Global OTC Oral Analgesics Revenue Market Share by Type (2021-2026) Table 7. Global OTC Oral Analgesics Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global OTC Oral Analgesics Revenue Market Share by Type (2027-2032) Table 9. Global OTC Oral Analgesics Market Size by Application (2021-2026) & (US$ Million) Table 10. Global OTC Oral Analgesics Revenue Market Share by Application (2021-2026) Table 11. Global OTC Oral Analgesics Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global OTC Oral Analgesics Revenue Market Share by Application (2027-2032) Table 13. Global OTC Oral Analgesics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global OTC Oral Analgesics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global OTC Oral Analgesics Market Share by Region (2021-2026) Table 16. Global OTC Oral Analgesics Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global OTC Oral Analgesics Market Share by Region (2027-2032) Table 18. OTC Oral Analgesics Industry Trends Table 19. OTC Oral Analgesics Industry Drivers Table 20. OTC Oral Analgesics Industry Opportunities and Challenges Table 21. OTC Oral Analgesics Market Restraints Table 22. Global Top OTC Oral Analgesics Players by Revenue (US$ Million) & (2021-2026) Table 23. Global OTC Oral Analgesics Revenue Market Share by Players (2021-2026) Table 24. Global OTC Oral Analgesics Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of OTC Oral Analgesics, Headquarters and Area Served Table 26. Global OTC Oral Analgesics Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global OTC Oral Analgesics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America OTC Oral Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 32. North America OTC Oral Analgesics Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe OTC Oral Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe OTC Oral Analgesics Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific OTC Oral Analgesics Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific OTC Oral Analgesics Market Size by Country (2027-2032) & (US$ Million) Table 39. South America OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America OTC Oral Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 41. South America OTC Oral Analgesics Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa OTC Oral Analgesics Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa OTC Oral Analgesics Market Size by Country (2027-2032) & (US$ Million) Table 45. Rundu Pharmaceutical Company Information Table 46. Rundu Pharmaceutical Business Overview Table 47. Rundu Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 48. Rundu Pharmaceutical OTC Oral Analgesics Product Portfolio Table 49. Rundu Pharmaceutical Recent Developments Table 50. Yuanhe Pharmaceutical Company Information Table 51. Yuanhe Pharmaceutical Business Overview Table 52. Yuanhe Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 53. Yuanhe Pharmaceutical OTC Oral Analgesics Product Portfolio Table 54. Yuanhe Pharmaceutical Recent Developments Table 55. Xinxiang Xinhui Yaoye Company Information Table 56. Xinxiang Xinhui Yaoye Business Overview Table 57. Xinxiang Xinhui Yaoye Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 58. Xinxiang Xinhui Yaoye OTC Oral Analgesics Product Portfolio Table 59. Xinxiang Xinhui Yaoye Recent Developments Table 60. Southwest Pharmaceutical Company Information Table 61. Southwest Pharmaceutical Business Overview Table 62. Southwest Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 63. Southwest Pharmaceutical OTC Oral Analgesics Product Portfolio Table 64. Southwest Pharmaceutical Recent Developments Table 65. Topfond Pharmaceutical Company Information Table 66. Topfond Pharmaceutical Business Overview Table 67. Topfond Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 68. Topfond Pharmaceutical OTC Oral Analgesics Product Portfolio Table 69. Topfond Pharmaceutical Recent Developments Table 70. Sun Pharmaceutical Company Information Table 71. Sun Pharmaceutical Business Overview Table 72. Sun Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 73. Sun Pharmaceutical OTC Oral Analgesics Product Portfolio Table 74. Sun Pharmaceutical Recent Developments Table 75. Sandoz Company Information Table 76. Sandoz Business Overview Table 77. Sandoz Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 78. Sandoz OTC Oral Analgesics Product Portfolio Table 79. Sandoz Recent Developments Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 83. Sanofi OTC Oral Analgesics Product Portfolio Table 84. Sanofi Recent Developments Table 85. Johnson & Johnson Company Information Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 88. Johnson & Johnson OTC Oral Analgesics Product Portfolio Table 89. Johnson & Johnson Recent Developments Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 93. Novartis OTC Oral Analgesics Product Portfolio Table 94. Novartis Recent Developments Table 95. Jiangxi Pharmaceutical Company Information Table 96. Jiangxi Pharmaceutical Business Overview Table 97. Jiangxi Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 98. Jiangxi Pharmaceutical OTC Oral Analgesics Product Portfolio Table 99. Jiangxi Pharmaceutical Recent Developments Table 100. Hongxing Pharmaceutical Company Information Table 101. Hongxing Pharmaceutical Business Overview Table 102. Hongxing Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 103. Hongxing Pharmaceutical OTC Oral Analgesics Product Portfolio Table 104. Hongxing Pharmaceutical Recent Developments Table 105. Pfizer Company Information Table 106. Pfizer Business Overview Table 107. Pfizer Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 108. Pfizer OTC Oral Analgesics Product Portfolio Table 109. Pfizer Recent Developments Table 110. Huazhong Pharmaceutical Company Information Table 111. Huazhong Pharmaceutical Business Overview Table 112. Huazhong Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 113. Huazhong Pharmaceutical OTC Oral Analgesics Product Portfolio Table 114. Huazhong Pharmaceutical Recent Developments Table 115. Dingchang Pharmaceutical Company Information Table 116. Dingchang Pharmaceutical Business Overview Table 117. Dingchang Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 118. Dingchang Pharmaceutical OTC Oral Analgesics Product Portfolio Table 119. Dingchang Pharmaceutical Recent Developments Table 120. Guangdong Heping Pharmacy Company Information Table 121. Guangdong Heping Pharmacy Business Overview Table 122. Guangdong Heping Pharmacy Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 123. Guangdong Heping Pharmacy OTC Oral Analgesics Product Portfolio Table 124. Guangdong Heping Pharmacy Recent Developments Table 125. Bangmin Pharmaceutical Company Information Table 126. Bangmin Pharmaceutical Business Overview Table 127. Bangmin Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 128. Bangmin Pharmaceutical OTC Oral Analgesics Product Portfolio Table 129. Bangmin Pharmaceutical Recent Developments Table 130. GSK Company Information Table 131. GSK Business Overview Table 132. GSK Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 133. GSK OTC Oral Analgesics Product Portfolio Table 134. GSK Recent Developments Table 135. Bayer Company Information Table 136. Bayer Business Overview Table 137. Bayer Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 138. Bayer OTC Oral Analgesics Product Portfolio Table 139. Bayer Recent Developments Table 140. AstraZeneca Company Information Table 141. AstraZeneca Business Overview Table 142. AstraZeneca Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 143. AstraZeneca OTC Oral Analgesics Product Portfolio Table 144. AstraZeneca Recent Developments Table 145. Taisho Pharmaceutical Company Information Table 146. Taisho Pharmaceutical Business Overview Table 147. Taisho Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 148. Taisho Pharmaceutical OTC Oral Analgesics Product Portfolio Table 149. Taisho Pharmaceutical Recent Developments Table 150. SSP Co. Ltd. Company Information Table 151. SSP Co. Ltd. Business Overview Table 152. SSP Co. Ltd. Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 153. SSP Co. Ltd. OTC Oral Analgesics Product Portfolio Table 154. SSP Co. Ltd. Recent Developments Table 155. MSD Company Information Table 156. MSD Business Overview Table 157. MSD Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 158. MSD OTC Oral Analgesics Product Portfolio Table 159. MSD Recent Developments Table 160. Merck Group Company Information Table 161. Merck Group Business Overview Table 162. Merck Group Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 163. Merck Group OTC Oral Analgesics Product Portfolio Table 164. Merck Group Recent Developments Table 165. Mallinckrodt Company Information Table 166. Mallinckrodt Business Overview Table 167. Mallinckrodt Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 168. Mallinckrodt OTC Oral Analgesics Product Portfolio Table 169. Mallinckrodt Recent Developments Table 170. Kowa Company Company Information Table 171. Kowa Company Business Overview Table 172. Kowa Company Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 173. Kowa Company OTC Oral Analgesics Product Portfolio Table 174. Kowa Company Recent Developments Table 175. Janssen Pharmaceuticals Company Information Table 176. Janssen Pharmaceuticals Business Overview Table 177. Janssen Pharmaceuticals Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 178. Janssen Pharmaceuticals OTC Oral Analgesics Product Portfolio Table 179. Janssen Pharmaceuticals Recent Developments Table 180. Hisamitsu Pharmaceutical Company Information Table 181. Hisamitsu Pharmaceutical Business Overview Table 182. Hisamitsu Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 183. Hisamitsu Pharmaceutical OTC Oral Analgesics Product Portfolio Table 184. Hisamitsu Pharmaceutical Recent Developments Table 185. Endo Pharmaceuticals Company Information Table 186. Endo Pharmaceuticals Business Overview Table 187. Endo Pharmaceuticals Revenue in OTC Oral Analgesics Business (2021-2026) & (US$ Million) Table 188. Endo Pharmaceuticals OTC Oral Analgesics Product Portfolio Table 189. Endo Pharmaceuticals Recent Developments Table 190. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. OTC Oral Analgesics Product Image Figure 5. Global OTC Oral Analgesics Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global OTC Oral Analgesics Market Share by Type: 2025 VS 2032 Figure 7. Aspirin Product Figure 8. Ibuprofen Product Figure 9. Acetaminophen Product Figure 10. Naproxen Product Figure 11. Other Product Figure 12. Global OTC Oral Analgesics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global OTC Oral Analgesics Market Share by Application: 2025 VS 2032 Figure 14. Hospital Pharmacies Product Figure 15. Online Pharmacies Product Figure 16. Retail Pharmacies Product Figure 17. Global OTC Oral Analgesics Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 18. Global OTC Oral Analgesics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global OTC Oral Analgesics Market Share by Region: 2025 VS 2032 Figure 20. Global OTC Oral Analgesics Market Share by Players in 2025 Figure 21. Global OTC Oral Analgesics Manufacturers Established Date Figure 22. Global Top 5 and 10 OTC Oral Analgesics Players Market Share by Revenue in 2025 Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 24. North America OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. North America OTC Oral Analgesics Market Share by Country (2021-2032) Figure 26. United States OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Canada OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 28. Mexico OTC Oral Analgesics Market Share by Country (2021-2032) Figure 29. Europe OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe OTC Oral Analgesics Market Share by Country (2021-2032) Figure 31. Germany OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. France OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. U.K. OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Italy OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Spain OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Russia OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Netherlands OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Nordic Countries OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 40. Asia-Pacific OTC Oral Analgesics Market Share by Country (2021-2032) Figure 41. China OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. Japan OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. South Korea OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 45. India OTC Oral Analgesics Market Share by Country (2021-2032) Figure 46. Australia OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. China Taiwan OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. Southeast Asia OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 50. South America OTC Oral Analgesics Market Share by Country (2021-2032) Figure 51. Brazil OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Argentina OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Chile OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Colombia OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Peru OTC Oral Analgesics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 56. Rundu Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 57. Yuanhe Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 58. Xinxiang Xinhui Yaoye Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 59. Southwest Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 60. Topfond Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 61. Sun Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 62. Sandoz Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 63. Sanofi Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 64. Johnson & Johnson Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 65. Novartis Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 66. Jiangxi Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 67. Hongxing Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 68. Pfizer Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 69. Huazhong Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 70. Dingchang Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 71. Guangdong Heping Pharmacy Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 72. Bangmin Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 73. GSK Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 74. Bayer Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 75. AstraZeneca Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 76. Taisho Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 77. SSP Co. Ltd. Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 78. MSD Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 79. Merck Group Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 80. Mallinckrodt Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 81. Kowa Company Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 82. Janssen Pharmaceuticals Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 83. Hisamitsu Pharmaceutical Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026) Figure 84. Endo Pharmaceuticals Revenue Growth Rate in OTC Oral Analgesics Business (2021-2026)

Scope & coverage.

Types
  • Aspirin
  • Ibuprofen
  • Acetaminophen
  • Naproxen
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Rundu Pharmaceutical
  • Yuanhe Pharmaceutical
  • Xinxiang Xinhui Yaoye
  • Southwest Pharmaceutical
  • Topfond Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Jiangxi Pharmaceutical
  • Hongxing Pharmaceutical
  • Pfizer
  • Huazhong Pharmaceutical
  • Dingchang Pharmaceutical
  • Guangdong Heping Pharmacy
  • Bangmin Pharmaceutical
  • GSK
  • Bayer
  • AstraZeneca
  • Taisho Pharmaceutical
  • SSP Co. Ltd.
  • MSD
  • Merck Group
  • Mallinckrodt
  • Kowa Company
  • Janssen Pharmaceuticals
  • Hisamitsu Pharmaceutical
  • Endo Pharmaceuticals

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 OTC Oral Analgesics by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Aspirin
  5. 2.2.3 Ibuprofen
  6. 2.2.4 Acetaminophen
  7. 2.2.5 Naproxen
  8. 2.2.6 Other
  9. 2.3 OTC Oral Analgesics by Application
  10. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  11. 2.3.2 Hospital Pharmacies
  12. 2.3.3 Online Pharmacies
  13. 2.3.4 Retail Pharmacies
  14. 2.4 Assumptions and Limitations
3 OTC Oral Analgesics Breakdown Data by Type
  1. 3.1 Global OTC Oral Analgesics Historic Market Size by Type (2021-2026)
  2. 3.2 Global OTC Oral Analgesics Forecasted Market Size by Type (2027-2032)
4 OTC Oral Analgesics Breakdown Data by Application
  1. 4.1 Global OTC Oral Analgesics Historic Market Size by Application (2021-2026)
  2. 4.2 Global OTC Oral Analgesics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global OTC Oral Analgesics Market Perspective (2021-2032)
  2. 5.2 Global OTC Oral Analgesics Growth Trends by Region
  3. 5.2.1 Global OTC Oral Analgesics Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 OTC Oral Analgesics Historic Market Size by Region (2021-2026)
  5. 5.2.3 OTC Oral Analgesics Forecasted Market Size by Region (2027-2032)
  6. 5.3 OTC Oral Analgesics Market Dynamics
  7. 5.3.1 OTC Oral Analgesics Industry Trends
  8. 5.3.2 OTC Oral Analgesics Market Drivers
  9. 5.3.3 OTC Oral Analgesics Market Challenges
  10. 5.3.4 OTC Oral Analgesics Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top OTC Oral Analgesics Players by Revenue
  2. 6.1.1 Global Top OTC Oral Analgesics Players by Revenue (2021-2026)
  3. 6.1.2 Global OTC Oral Analgesics Revenue Market Share by Players (2021-2026)
  4. 6.2 Global OTC Oral Analgesics Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of OTC Oral Analgesics Head Office and Area Served
  6. 6.4 Global OTC Oral Analgesics Players, Product Type & Application
  7. 6.5 Global OTC Oral Analgesics Manufacturers Established Date
  8. 6.6 Global OTC Oral Analgesics Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America OTC Oral Analgesics Market Size (2021-2032)
  2. 7.2 North America OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America OTC Oral Analgesics Market Size by Country (2021-2026)
  4. 7.4 North America OTC Oral Analgesics Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe OTC Oral Analgesics Market Size (2021-2032)
  2. 8.2 Europe OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe OTC Oral Analgesics Market Size by Country (2021-2026)
  4. 8.4 Europe OTC Oral Analgesics Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific OTC Oral Analgesics Market Size (2021-2032)
  2. 9.2 Asia-Pacific OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific OTC Oral Analgesics Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific OTC Oral Analgesics Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America OTC Oral Analgesics Market Size (2021-2032)
  2. 10.2 South America OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America OTC Oral Analgesics Market Size by Country (2021-2026)
  4. 10.4 South America OTC Oral Analgesics Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa OTC Oral Analgesics Market Size (2021-2032)
  2. 11.2 Middle East & Africa OTC Oral Analgesics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa OTC Oral Analgesics Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa OTC Oral Analgesics Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Rundu Pharmaceutical
  2. 12.1.1 Rundu Pharmaceutical Company Information
  3. 12.1.2 Rundu Pharmaceutical Business Overview
  4. 12.1.3 Rundu Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  5. 12.1.4 Rundu Pharmaceutical OTC Oral Analgesics Product Portfolio
  6. 12.1.5 Rundu Pharmaceutical Recent Developments
  7. 12.2 Yuanhe Pharmaceutical
  8. 12.2.1 Yuanhe Pharmaceutical Company Information
  9. 12.2.2 Yuanhe Pharmaceutical Business Overview
  10. 12.2.3 Yuanhe Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  11. 12.2.4 Yuanhe Pharmaceutical OTC Oral Analgesics Product Portfolio
  12. 12.2.5 Yuanhe Pharmaceutical Recent Developments
  13. 12.3 Xinxiang Xinhui Yaoye
  14. 12.3.1 Xinxiang Xinhui Yaoye Company Information
  15. 12.3.2 Xinxiang Xinhui Yaoye Business Overview
  16. 12.3.3 Xinxiang Xinhui Yaoye Revenue in OTC Oral Analgesics Business (2021-2026)
  17. 12.3.4 Xinxiang Xinhui Yaoye OTC Oral Analgesics Product Portfolio
  18. 12.3.5 Xinxiang Xinhui Yaoye Recent Developments
  19. 12.4 Southwest Pharmaceutical
  20. 12.4.1 Southwest Pharmaceutical Company Information
  21. 12.4.2 Southwest Pharmaceutical Business Overview
  22. 12.4.3 Southwest Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  23. 12.4.4 Southwest Pharmaceutical OTC Oral Analgesics Product Portfolio
  24. 12.4.5 Southwest Pharmaceutical Recent Developments
  25. 12.5 Topfond Pharmaceutical
  26. 12.5.1 Topfond Pharmaceutical Company Information
  27. 12.5.2 Topfond Pharmaceutical Business Overview
  28. 12.5.3 Topfond Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  29. 12.5.4 Topfond Pharmaceutical OTC Oral Analgesics Product Portfolio
  30. 12.5.5 Topfond Pharmaceutical Recent Developments
  31. 12.6 Sun Pharmaceutical
  32. 12.6.1 Sun Pharmaceutical Company Information
  33. 12.6.2 Sun Pharmaceutical Business Overview
  34. 12.6.3 Sun Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  35. 12.6.4 Sun Pharmaceutical OTC Oral Analgesics Product Portfolio
  36. 12.6.5 Sun Pharmaceutical Recent Developments
  37. 12.7 Sandoz
  38. 12.7.1 Sandoz Company Information
  39. 12.7.2 Sandoz Business Overview
  40. 12.7.3 Sandoz Revenue in OTC Oral Analgesics Business (2021-2026)
  41. 12.7.4 Sandoz OTC Oral Analgesics Product Portfolio
  42. 12.7.5 Sandoz Recent Developments
  43. 12.8 Sanofi
  44. 12.8.1 Sanofi Company Information
  45. 12.8.2 Sanofi Business Overview
  46. 12.8.3 Sanofi Revenue in OTC Oral Analgesics Business (2021-2026)
  47. 12.8.4 Sanofi OTC Oral Analgesics Product Portfolio
  48. 12.8.5 Sanofi Recent Developments
  49. 12.9 Johnson & Johnson
  50. 12.9.1 Johnson & Johnson Company Information
  51. 12.9.2 Johnson & Johnson Business Overview
  52. 12.9.3 Johnson & Johnson Revenue in OTC Oral Analgesics Business (2021-2026)
  53. 12.9.4 Johnson & Johnson OTC Oral Analgesics Product Portfolio
  54. 12.9.5 Johnson & Johnson Recent Developments
  55. 12.10 Novartis
  56. 12.10.1 Novartis Company Information
  57. 12.10.2 Novartis Business Overview
  58. 12.10.3 Novartis Revenue in OTC Oral Analgesics Business (2021-2026)
  59. 12.10.4 Novartis OTC Oral Analgesics Product Portfolio
  60. 12.10.5 Novartis Recent Developments
  61. 12.11 Jiangxi Pharmaceutical
  62. 12.11.1 Jiangxi Pharmaceutical Company Information
  63. 12.11.2 Jiangxi Pharmaceutical Business Overview
  64. 12.11.3 Jiangxi Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  65. 12.11.4 Jiangxi Pharmaceutical OTC Oral Analgesics Product Portfolio
  66. 12.11.5 Jiangxi Pharmaceutical Recent Developments
  67. 12.12 Hongxing Pharmaceutical
  68. 12.12.1 Hongxing Pharmaceutical Company Information
  69. 12.12.2 Hongxing Pharmaceutical Business Overview
  70. 12.12.3 Hongxing Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  71. 12.12.4 Hongxing Pharmaceutical OTC Oral Analgesics Product Portfolio
  72. 12.12.5 Hongxing Pharmaceutical Recent Developments
  73. 12.13 Pfizer
  74. 12.13.1 Pfizer Company Information
  75. 12.13.2 Pfizer Business Overview
  76. 12.13.3 Pfizer Revenue in OTC Oral Analgesics Business (2021-2026)
  77. 12.13.4 Pfizer OTC Oral Analgesics Product Portfolio
  78. 12.13.5 Pfizer Recent Developments
  79. 12.14 Huazhong Pharmaceutical
  80. 12.14.1 Huazhong Pharmaceutical Company Information
  81. 12.14.2 Huazhong Pharmaceutical Business Overview
  82. 12.14.3 Huazhong Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  83. 12.14.4 Huazhong Pharmaceutical OTC Oral Analgesics Product Portfolio
  84. 12.14.5 Huazhong Pharmaceutical Recent Developments
  85. 12.15 Dingchang Pharmaceutical
  86. 12.15.1 Dingchang Pharmaceutical Company Information
  87. 12.15.2 Dingchang Pharmaceutical Business Overview
  88. 12.15.3 Dingchang Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  89. 12.15.4 Dingchang Pharmaceutical OTC Oral Analgesics Product Portfolio
  90. 12.15.5 Dingchang Pharmaceutical Recent Developments
  91. 12.16 Guangdong Heping Pharmacy
  92. 12.16.1 Guangdong Heping Pharmacy Company Information
  93. 12.16.2 Guangdong Heping Pharmacy Business Overview
  94. 12.16.3 Guangdong Heping Pharmacy Revenue in OTC Oral Analgesics Business (2021-2026)
  95. 12.16.4 Guangdong Heping Pharmacy OTC Oral Analgesics Product Portfolio
  96. 12.16.5 Guangdong Heping Pharmacy Recent Developments
  97. 12.17 Bangmin Pharmaceutical
  98. 12.17.1 Bangmin Pharmaceutical Company Information
  99. 12.17.2 Bangmin Pharmaceutical Business Overview
  100. 12.17.3 Bangmin Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  101. 12.17.4 Bangmin Pharmaceutical OTC Oral Analgesics Product Portfolio
  102. 12.17.5 Bangmin Pharmaceutical Recent Developments
  103. 12.18 GSK
  104. 12.18.1 GSK Company Information
  105. 12.18.2 GSK Business Overview
  106. 12.18.3 GSK Revenue in OTC Oral Analgesics Business (2021-2026)
  107. 12.18.4 GSK OTC Oral Analgesics Product Portfolio
  108. 12.18.5 GSK Recent Developments
  109. 12.19 Bayer
  110. 12.19.1 Bayer Company Information
  111. 12.19.2 Bayer Business Overview
  112. 12.19.3 Bayer Revenue in OTC Oral Analgesics Business (2021-2026)
  113. 12.19.4 Bayer OTC Oral Analgesics Product Portfolio
  114. 12.19.5 Bayer Recent Developments
  115. 12.20 AstraZeneca
  116. 12.20.1 AstraZeneca Company Information
  117. 12.20.2 AstraZeneca Business Overview
  118. 12.20.3 AstraZeneca Revenue in OTC Oral Analgesics Business (2021-2026)
  119. 12.20.4 AstraZeneca OTC Oral Analgesics Product Portfolio
  120. 12.20.5 AstraZeneca Recent Developments
  121. 12.21 Taisho Pharmaceutical
  122. 12.21.1 Taisho Pharmaceutical Company Information
  123. 12.21.2 Taisho Pharmaceutical Business Overview
  124. 12.21.3 Taisho Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  125. 12.21.4 Taisho Pharmaceutical OTC Oral Analgesics Product Portfolio
  126. 12.21.5 Taisho Pharmaceutical Recent Developments
  127. 12.22 SSP Co. Ltd.
  128. 12.22.1 SSP Co. Ltd. Company Information
  129. 12.22.2 SSP Co. Ltd. Business Overview
  130. 12.22.3 SSP Co. Ltd. Revenue in OTC Oral Analgesics Business (2021-2026)
  131. 12.22.4 SSP Co. Ltd. OTC Oral Analgesics Product Portfolio
  132. 12.22.5 SSP Co. Ltd. Recent Developments
  133. 12.23 MSD
  134. 12.23.1 MSD Company Information
  135. 12.23.2 MSD Business Overview
  136. 12.23.3 MSD Revenue in OTC Oral Analgesics Business (2021-2026)
  137. 12.23.4 MSD OTC Oral Analgesics Product Portfolio
  138. 12.23.5 MSD Recent Developments
  139. 12.24 Merck Group
  140. 12.24.1 Merck Group Company Information
  141. 12.24.2 Merck Group Business Overview
  142. 12.24.3 Merck Group Revenue in OTC Oral Analgesics Business (2021-2026)
  143. 12.24.4 Merck Group OTC Oral Analgesics Product Portfolio
  144. 12.24.5 Merck Group Recent Developments
  145. 12.25 Mallinckrodt
  146. 12.25.1 Mallinckrodt Company Information
  147. 12.25.2 Mallinckrodt Business Overview
  148. 12.25.3 Mallinckrodt Revenue in OTC Oral Analgesics Business (2021-2026)
  149. 12.25.4 Mallinckrodt OTC Oral Analgesics Product Portfolio
  150. 12.25.5 Mallinckrodt Recent Developments
  151. 12.26 Kowa Company
  152. 12.26.1 Kowa Company Company Information
  153. 12.26.2 Kowa Company Business Overview
  154. 12.26.3 Kowa Company Revenue in OTC Oral Analgesics Business (2021-2026)
  155. 12.26.4 Kowa Company OTC Oral Analgesics Product Portfolio
  156. 12.26.5 Kowa Company Recent Developments
  157. 12.27 Janssen Pharmaceuticals
  158. 12.27.1 Janssen Pharmaceuticals Company Information
  159. 12.27.2 Janssen Pharmaceuticals Business Overview
  160. 12.27.3 Janssen Pharmaceuticals Revenue in OTC Oral Analgesics Business (2021-2026)
  161. 12.27.4 Janssen Pharmaceuticals OTC Oral Analgesics Product Portfolio
  162. 12.27.5 Janssen Pharmaceuticals Recent Developments
  163. 12.28 Hisamitsu Pharmaceutical
  164. 12.28.1 Hisamitsu Pharmaceutical Company Information
  165. 12.28.2 Hisamitsu Pharmaceutical Business Overview
  166. 12.28.3 Hisamitsu Pharmaceutical Revenue in OTC Oral Analgesics Business (2021-2026)
  167. 12.28.4 Hisamitsu Pharmaceutical OTC Oral Analgesics Product Portfolio
  168. 12.28.5 Hisamitsu Pharmaceutical Recent Developments
  169. 12.29 Endo Pharmaceuticals
  170. 12.29.1 Endo Pharmaceuticals Company Information
  171. 12.29.2 Endo Pharmaceuticals Business Overview
  172. 12.29.3 Endo Pharmaceuticals Revenue in OTC Oral Analgesics Business (2021-2026)
  173. 12.29.4 Endo Pharmaceuticals OTC Oral Analgesics Product Portfolio
  174. 12.29.5 Endo Pharmaceuticals Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst